Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: AISAP does not list a price
Free plan
Tie
Neither has one
Higher rating
PathAI
4.1 against 4.3
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
AISAP
PathAI
Our rating
4.1
4.3Better
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
Real-time AI interpretation of cardiac ultrasound images at the bedside
FDA clearance in the CADx pathway for structural heart disease diagnosis via POCUS
Structured, auto-generated reporting that cuts documentation time
Works with existing ultrasound hardware rather than a proprietary probe
Integrates with PACS and EMR systems already in place
AISight Dx analyzes digital pathology slide images to assist diagnosis
FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
Predetermined Change Control Plan allows faster future software updates
Expanded Labcorp collaboration deploying nationwide as of February 2026
FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
Pros
FDA clearance gives it regulatory standing competitors without clearance lack
Hardware-agnostic approach avoids locking hospitals into new ultrasound equipment
Backed by practicing cardiologists as co-founders, not only engineers
Genuine FDA clearance for primary diagnosis, not just an assistive tool
Predetermined Change Control Plan speeds up future regulatory-approved updates
National-scale deployment through Labcorp validates real clinical trust
Cons
Pricing is entirely custom and undisclosed, making budget comparison hard upfront
Aimed at institutions rather than individual clinicians shopping for a personal tool
Regulatory clearance is specific to cardiac and structural heart disease, not general ultrasound reading
Enterprise quote-based pricing requires a sales conversation, no published rates
Built specifically for pathology labs, not applicable to other clinical specialties
Regulatory-cleared medical device status means slower iteration than software-only tools
Company
AISAP, founded 2021
PathAI, founded 2016
Prices come from each vendor's pricing page, last checked 20260730. Check the vendor before you buy.
FAQ
Questions people ask
Is AISAP better than PathAI?
In our reviews AISAP scores 4.1 and PathAI scores 4.3. The better pick depends on the job. AISAP: An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.
PathAI
AISAP
